Literature DB >> 16015073

Lupus miliaris disseminatus faciei part II: an overview.

Virendra N Sehgal1, Govind Srivastava, Ashok K Aggarwal, Viswanath R Belum, Vishwanath Reddy, Sonal Sharma.   

Abstract

Lupus miliaris disseminatus faciei, a chronic inflammatory disorder, is a controversial and enigmatic diagnostic/therapeutic entity. Multiple, discrete, smooth 1-3 mm brown/red or brown-to-yellowish dome-shaped papules (sometimes with mild scaling) are its clinical characteristics. The lesions are usually located on the central and lateral side of the face. The condition is most often seen in young adults of both sexes, and diascopy may reveal apple-jelly nodules. Lupus miliaris disseminatus faciei has clearly been defined into four histopathologic groups: epithelioid cell granuloma with central necrosis; epithelioid cell granuloma without central necrosis (sarcoid/foreign body reaction); epithelioid cell granuloma with abscesses; and nongranulomatous, nonspecific inflammatory infiltrate. While in early lesions granuloma is absent and lymphocytes and a few neutrophils surround the follicles, fully developed lesions show well formed granuloma surrounding ruptured hair follicles, often with large numbers of neutrophils. Lupus miliaris disseminatus faciei must be differentiated from other conditions; to facilitate this, in Part I of this paper the histopathologic undertones were delineated into early, intermediate (first stage, second stage, and third stage), and late stages. This part of the article presents an overview of lupus miliaris disseminatus faciei.

Entities:  

Mesh:

Year:  2005        PMID: 16015073

Source DB:  PubMed          Journal:  Skinmed        ISSN: 1540-9740


  7 in total

1.  Lupus miliaris disseminatus faciei with unusual distribution of lesions.

Authors:  Amiya Kumar Nath; R Sivaranjini; Devinder Mohan Thappa; Debdatta Basu
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

2.  Lewandowsky's Rosaceiform Eruption: a Form of Cutaneous Tuberculosis Confirmed by PCR in Two Patients.

Authors:  Rodrigo Conlledo; Antonio Guglielmetti; Macarena Sobarzo; Francisca Woolvett; Francisca Bravo; Sergio González; Félix Fich; Verónica Vial
Journal:  Dermatol Ther (Heidelb)       Date:  2014-12-18

3.  Extrafacial nuchal lupus miliaris disseminatus faciei.

Authors:  Laura G Pruitt; Carley O Fowler; Robert N Page; Neil M Coleman; Roy King
Journal:  JAAD Case Rep       Date:  2017-07-18

4.  Lupus Miliaris Disseminatus Faciei: A Case Report and Brief Literature Review.

Authors:  Aslı Aksu Çerman; Ezgi Aktaş Karabay; Özben Yalçın; Ilknur Kıvanç Altunay
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2018-05-28

5.  Morbihan disease and extrafacial lupus miliaris disseminatus faceie: a case report.

Authors:  Kenzen Kou; Keishi Chin; Setsuko Matsukura; Takeshi Sasaki; Akinori Nozawa; Michiko Aihara; Takeshi Kambara
Journal:  Ann Saudi Med       Date:  2014 Jul-Aug       Impact factor: 1.526

6.  Recalcitrant lupus miliaris disseminatus faciei improved by cyclosporine monotherapy.

Authors:  Hyeok-Jin Kwon; Kyung-Deok Park; Dong-Wha Yoo; Jeong-Wan Seo; Ki-Ho Kim; Jung-Ho Yoon
Journal:  JAAD Case Rep       Date:  2022-07-06

7.  Lupus Miliaris Disseminatus Faciei versus Granulomatous Rosacea: A Case Report.

Authors:  Ji-In Seo; Min Kyung Shin
Journal:  Case Rep Dermatol       Date:  2021-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.